Oncology

Yale Cancer Center invested $1.5 million to improve its hematology/oncology fellowship program, it said Feb. 18.

Rutgers Cancer Institute of New Jersey named Sanjay Goel, MD, director of its investigational therapeutics program, it said Feb. 16.

The University of Texas MD Anderson Cancer Center was awarded $31.7 million from the Cancer Prevention and Research Institute of Texas, the center said Feb. 16.

The University of Texas MD Anderson Cancer Center extended its partnership with Phoenix-based Banner Health for another 10 years, the cancer center said Feb. 15. 

Delayed screenings as a result of the COVID-19 pandemic have led to later-stage cancer diagnoses, a small study published Feb. 15 in JAMA Network Open suggests.

Yale Cancer Center recently made several leadership changes. 

The use of genomic sequencing to predict the likelihood that gastric cancer patients will  benefit from chemotherapy or from immunotherapy has been validated by findings in a study published Feb. 9 in Nature Communications.

While the White House's revival of the Cancer Moonshot — a program to cut cancer deaths by 50 percent over the next 25 years — is an ambitious and important goal, more can be done today to benefit cancer patients,…

Recent cancer research has findings on cancer trends among African Americans and the impact of COVID-19 on cancer research.

Yale Cancer Center appointed Roy Herbst, MD, its inaugural deputy director of clinical affairs at the center and New Haven, Conn.-based Smilow Cancer Hospital, the center said last week.